Literature DB >> 31047110

The role of microRNAs in chronic pseudomonas lung infection in Cystic fibrosis.

Katherine Fesen1, Patricia Silveyra2, Nathalie Fuentes1, Marvin Nicoleau1, Lidys Rivera1, Diane Kitch1, Gavin R Graff1, Roopa Siddaiah3.   

Abstract

BACKGROUND: Cystic Fibrosis (CF) is the most common life limiting genetic disorder, characterized by chronic respiratory failure secondary to inflammation and chronic bacterial lung infection. Pseudomonas aeruginosa lung infection is associated with more severe lung disease and rapid progression of respiratory failure when compared to Staphylococcus aureus infection. We hypothesized that a specific signature of epigenetic factors targeting specific gene transcripts contributes to the increased morbidity seen in CF patients with chronic Pseudomonas infection.
METHODS: We collected exhaled breath condensate (EBC) from 27 subjects and evaluated miRNA signatures in these samples using commercial PCR array. We identified predicted mRNA targets and associated signaling pathways using Ingenuity Pathway Analysis.
RESULTS: We found 11 differentially expressed miRNAs in EBC of patients infected with Pseudomonas aeruginosa compared to EBC from CF patients who were not chronically infected with Pseudomonas aeruginosa (p < 0.05). Six of these miRNAs (hsa-miRNA-1247, hsa-miRNA-1276, hsa-miRNA-449c, hsa-miRNA-3170, hsa-miRNA-432-5p and hsa-miR-548) were significantly different in the CF Pseudomonas positive group when compared to both the CF Pseudomonas negative group and healthy control group. Ingenuity pathway analysis (IPA) revealed organismal injury and abnormalities, reproductive system disease and cancer as the top diseases and bio functions associated with these miRNAs. IPA also detected RELA, JUN, TNF, IL-10, CTNNB1, IL-13, SERPINB8, CALM1, STARD3NL, SFI1, CD55, RPS6KA4, TTC36 and HIST1H3D as the top target genes for these miRNAs.
CONCLUSION: Our study identified 6 miRNAs as epigenetic factors specifically associated with chronic Pseudomonas infection in patients with CF.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; MicroRNA; Pediatrics; Pseudomonas infection

Mesh:

Substances:

Year:  2019        PMID: 31047110     DOI: 10.1016/j.rmed.2019.04.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance.

Authors:  Chune Zhu; Jianting Chen; Shihui Yu; Chailu Que; Lynne S Taylor; Wen Tan; Chuanbin Wu; Qi Tony Zhou
Journal:  Mol Pharm       Date:  2020-07-24       Impact factor: 4.939

2.  Eosinophil microRNAs Play a Regulatory Role in Allergic Diseases Included in the Atopic March.

Authors:  Émile Bélanger; Anne-Marie Madore; Anne-Marie Boucher-Lafleur; Marie-Michelle Simon; Tony Kwan; Tomi Pastinen; Catherine Laprise
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

3.  MicroRNA Expression in Extracellular Vesicles from Nasal Lavage Fluid in Chronic Rhinosinusitis.

Authors:  Seungbin Cha; Eun-Hye Seo; Seung Hyun Lee; Kyung Soo Kim; Chung-Sik Oh; Jong-Seok Moon; Jin Kook Kim
Journal:  Biomedicines       Date:  2021-04-26

4.  An EBC/Plasma miRNA Signature Discriminates Lung Adenocarcinomas From Pleural Mesothelioma and Healthy Controls.

Authors:  Alice Faversani; Chiara Favero; Laura Dioni; Angela Cecilia Pesatori; Valentina Bollati; Matteo Montoli; Valeria Musso; Andrea Terrasi; Nicola Fusco; Mario Nosotti; Valentina Vaira; Alessandro Palleschi
Journal:  Front Oncol       Date:  2021-06-15       Impact factor: 6.244

Review 5.  Research advances in molecular mechanisms underlying the pathogenesis of cystic fibrosis: From technical improvement to clinical applications (Review).

Authors:  Tao Wei; Hongshu Sui; Yanping Su; Wanjing Cheng; Yunhua Liu; Zilin He; Qingchao Ji; Changlong Xu
Journal:  Mol Med Rep       Date:  2020-10-16       Impact factor: 2.952

6.  Fucoxanthin may inhibit cervical cancer cell proliferation via downregulation of HIST1H3D.

Authors:  Guoliu Ye; Lingling Wang; Kang Yang; Caizhi Wang
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.